Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Cardiovascular Research|March 7, 2020
Variations in incidence of venous thromboembolism in low-, middle-, and high-income countriesDeborah M Siegal, John W Eikelboom, Shun Fu Lee, et al.
Diabetes & Vascular Disease Research|March 23, 2021
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trialAnne Wang, Hertzel C Gerstein, Shun Fu Lee, et al.
Canadian Journal of Diabetes|August 6, 2025
Can a Combined Epigenetic-Biomarker Score Supplant Chronologic Age as an Independent Determinant of Incident Death in Adults with DysglycemiaHertzel C Gerstein, Guillaume Pare, Keyun Zhou, et al.
The Annals of Thoracic Surgery|August 25, 2024
Secondary Conduits in Coronary Artery Bypass Grafting SurgeryAustin Browne, Shun Fu Lee, Fraser Rubens, et al.
Diabetes & Vascular Disease Research|April 14, 2017
The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trialAslak Rautio, Kurt Boman, Hertzel C Gerstein, et al.
Diabetes Care|November 16, 2019
Novel Biomarkers for Change in Renal Function in People With DysglycemiaHertzel C Gerstein, Guillaume Paré, Matthew J McQueen, et al.
European Journal of Heart Failure|February 2, 2024
Effect of a transitional care model following hospitalization for heart failure: 3-year outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) randomized controlled trialTauben Averbuch, Shun Fu Lee, Brandon Zagorski, et al.
European Journal of Preventive Cardiology|December 21, 2018
Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trialAnne Wang, Stefan Arver, Kurt Boman, et al.
Diabetes, Obesity & Metabolism|September 12, 2018
The association of basal insulin treatment versus standard care with outcomes in anti-GAD positive and negative subjects: A post-hoc analysis of the ORIGIN trialKåre I Birkeland, Valdemar Grill, Cecilie Wium, et al.
Cerebral Circulation - Cognition and Behavior|May 27, 2024
Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: A cohort studyLaura Sherlock, Shun Fu Lee, Tali Cukierman-Yaffe, et al.
Pageof 8